What in the drug development process is most important to patients? The new FDA draft guidance on Patient-Focused Drug Development released September 30, 2019, provides quantitative and qualitative methods for sponsors to measure a patient’s experience with respect to disease burden and treatment. FDA invites comments until the end of the year.
Want to dig deeper into patient-focused drug development?
-
Article
Assessing Biopharmaceutical Company Experience with Patient-Centric Initiatives
Read Now
Clinical Therapeutics
Debra L. Michaels, Mary Jo Lamberti, Yaritza Pena, Barbara Lopez Kunz, Kenneth Getz -
Article
Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and Development
Read Now
Stella Stergiopoulos, Debra L. Michaels, Barbara Lopez Kunz, Kenneth Getz
Therapeutic Innovation & Regulatory Science
Member-only content
-
Article
Dear Sponsor: The Patient Will See You Now – Tipping Point in Clinical Research
Read Now
Roslyn Schneider, Richard Stephens, Tony Hoos, Lode Dewulf
Global Forum -
Article
Role of Patients and Parents in Pediatric Drug Development
Read Now
Vivian W. L. Tsang et al.
Therapeutic Innovation & Regulatory Science
Member-only content
-
Podcast
The Patient's Most Engaging Question: Why?
Listen Now
Deborah Collyar, Lode Dewulf -
Article
Mapping the Landscape of Patient-Centric Activities Within Clinical Research
Read Now
Mary Jo Lamberti, Josephine Awatin
Clinical Therapeutics -
Article
Pharmacovigilance: Towards 2020 and Beyond
Read Now
Chris M. Slawecki
Global Forum -
Article
The Potential Role of Individual-Level Benefit-Risk Assessment in Treatment Decision Making: A DIA Study Endpoints Community Workstream
Read Now
Matthew Reaney et al.
Therapeutic Innovation & Regulatory Science
Member-only content
-
Article
Incorporating Patient Advocates in Oncology Clinical Development: Lessons Learned From a Novel Pilot Program
Read Now
Wendy Selig, Ian Banks, Anjelica Davis, Gissoo DeCotiis, Ryan Hohman, Lisa Schlager
Therapeutic Innovation & Regulatory Science
Member-only content
Want to learn more?
Check out INSIDER ACCESS: Making Clinical Trials Work for Special Populations – our exclusive content for DIA Members. A full-length transcript is also available. Or download DIA's Considerations Guide to Implementing Patient-Centric Initiatives in Healthcare Product Development and DIA's Patient Engagement Study Findings from our Collaboration with the Tufts Center for the Study of Drug Development (CSDD).
Related Perspectives
View all Deep Dives-
Article
From RAPS: Patient-Focused Drug Development: New FDA Draft Guidance Delves Into What’s Important
Read Now -
Article
From FDA: FDA Patient-Focused Drug Development Guidance Series for Enhancing the Incorporation of the Patient’s Voice in Medical Product Development and Regulatory Decision Making
Read Now